Tenon Medical, Inc. received notice from Nasdaq that it has regained compliance with the Stockholders' Equity Rule, which requires maintaining a minimum of $2.5 million in stockholders' equity. This compliance was achieved following the completion of a $4.2 million public offering of common stock and warrants on July 1, 2026. Tenon Medical, Inc. is a medical device company that develops and offers systems to treat sacro-pelvic disorders.

Tenon Medical, Inc. announced that following a $4.2 million public offering of common stock and warrants on July 1, 2026, the company believes it satisfies Nasdaq's minimum stockholders' equity requirement. Nasdaq will continue to monitor compliance, with a potential delisting risk if compliance is not evidenced by the company's September 30, 2026, Quarterly Report. Tenon Medical, Inc. is a medical device company focused on orthopedic surgery solutions.